- Home
- WULF vs RCKT Comparison
WULF vs RCKT Comparison
Compare WULF & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- RCKT
- Stock Information
- Founded
- WULF 1952
- RCKT 1999
- Country
- WULF United States
- RCKT United States
- Employees
- WULF N/A
- RCKT N/A
- Industry
- WULF EDP Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- RCKT Health Care
- Exchange
- WULF Nasdaq
- RCKT Nasdaq
- Market Cap
- WULF 1.8B
- RCKT 264.0M
- IPO Year
- WULF 1995
- RCKT N/A
- Fundamental
- Price
- WULF $4.86
- RCKT $2.81
- Analyst Decision
- WULF Strong Buy
- RCKT Buy
- Analyst Count
- WULF 8
- RCKT 13
- Target Price
- WULF $8.44
- RCKT $18.50
- AVG Volume (30 Days)
- WULF 55.3M
- RCKT 3.6M
- Earning Date
- WULF 08-11-2025
- RCKT 08-04-2025
- Dividend Yield
- WULF N/A
- RCKT N/A
- EPS Growth
- WULF N/A
- RCKT N/A
- EPS
- WULF N/A
- RCKT N/A
- Revenue
- WULF $132,023,000.00
- RCKT N/A
- Revenue This Year
- WULF $45.98
- RCKT N/A
- Revenue Next Year
- WULF $83.67
- RCKT N/A
- P/E Ratio
- WULF N/A
- RCKT N/A
- Revenue Growth
- WULF 31.85
- RCKT N/A
- 52 Week Low
- WULF $2.06
- RCKT $2.19
- 52 Week High
- WULF $9.30
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- WULF 57.44
- RCKT 41.85
- Support Level
- WULF $4.82
- RCKT $2.76
- Resistance Level
- WULF $5.34
- RCKT $3.24
- Average True Range (ATR)
- WULF 0.41
- RCKT 0.19
- MACD
- WULF 0.03
- RCKT 0.13
- Stochastic Oscillator
- WULF 67.61
- RCKT 49.10
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.